We are thrilled to spotlight Dr. Monica Bertagnolli as a significant figure in the oncology field.
Dr. Monica Bertagnolli is a leading oncologist and researcher who currently serves as the Director of the National Institutes of Health (NIH) in the United States. Her extensive career includes serving as President of the Alliance for Clinical Trials in Oncology Foundation.
Previously, she held the Richard E. Wilson Professorship of Surgery at Harvard Medical School, was a surgeon at Brigham and Women’s Hospital, and was a member of the Gastrointestinal Cancer Treatment and Sarcoma Centers at Dana-Farber Cancer Institute.
Dr. Bertagnolli is renowned for her pioneering work in oncology and has played a crucial role in advancing clinical research and treatment standards. She is the Founding Chair of the Minimal Common Oncology Data Elements (mCODE) Executive Committee, which aims to standardize cancer data to improve patient care and research.
Her leadership extends to her previous roles as Past President and Chair of the Board of Directors of the American Society of Clinical Oncology (ASCO) and her election to the National Academy of Medicine in 2021.
Follow Dr. Monica Bertagnolli on X/Twitter and LinkedIn to stay updated on her groundbreaking work in oncology and her significant contributions to advancing cancer research and treatment.
About Dr. Monica Bertagnolli
Dr. Monica Bertagnolli is a distinguished oncologist with a notable career in advancing cancer research and treatment. As the Director of the NIH, she leads efforts to foster innovation and improve patient outcomes on a national scale.
Her previous roles, including her tenure as President of the Alliance for Clinical Trials in Oncology Foundation and her leadership positions at Harvard Medical School and Dana-Farber Cancer Institute, underscore her influence in the field. Dr. Bertagnolli has also made significant contributions as the Founding Chair of the mCODE Executive Committee and has served in various capacities with national organizations, including ASCO.
In 2021, her expertise and leadership were further recognized with her election to the National Academy of Medicine, highlighting her profound impact on the field of oncology.
Stay tuned for more OncoInfluencers and explore previous profiles on our website to discover other leading voices in the oncology community.
